$PWOD
PENNS WOODS BANCORP INC Stock $pwod

$pwod Overview Financials Valuation SEC Filings Company Website

2018 Q1 Form 10-Q Financial Statement

#000071660518000012 Filed on May 10, 2018

Income Statement

Concept	2018 Q1	2017 Q1
Revenue	$13.20M	$11.68M
YoY Change	13.0%	-0.38%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$470.0K	$810.0K
YoY Change	-41.98%	-14.74%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$2.048M	$1.346M
YoY Change	52.15%	-0.44%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$3.797M	$3.672M
YoY Change	3.4%	-7.27%
Income Tax	$589.0K	$986.0K
% Of Pretax Income	15.51%	26.85%
Net Earnings	$3.209M	$2.686M
YoY Change	19.47%	-12.79%
Net Earnings / Revenue	24.31%	22.99%
Basic Earnings Per Share	$0.45	$0.57
Diluted Earnings Per Share	$0.45	$0.56
COMMON SHARES
Basic Shares Outstanding	4.689M shares	4.735M shares
Diluted Shares Outstanding	4.689M shares	4.761M shares

Balance Sheet

Concept	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$37.39M	$75.66M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$27.59M	$24.43M
YoY Change	12.92%	10.26%
Goodwill	$17.10M	$17.10M
YoY Change	0.0%	0.0%
Intangibles	$1.382M	$1.709M
YoY Change	-19.13%	-17.76%
Long-Term Investments		$500.0K
YoY Change		-28.57%
Other Assets	$4.700M	$8.000M
YoY Change	-41.25%	-4.76%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.527B	$1.401B
YoY Change	9.0%	6.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$800.0K	$400.0K
YoY Change	100.0%	0.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$59.31M	$8.589M
YoY Change	590.48%	-45.89%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$800.0K	$400.0K
YoY Change	100.0%	0.0%
LONG-TERM LIABILITIES
Long-Term Debt	$124.0M	$76.00M
YoY Change	63.16%	18900.0%
Other Long-Term Liabilities	$12.10M	$16.00M
YoY Change	-24.38%	17.65%
Total Long-Term Liabilities	$136.1M	$92.00M
YoY Change	47.93%	557.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$800.0K	$400.0K
Total Long-Term Liabilities	$136.1M	$92.00M
Total Liabilities	$1.389B	$1.262B
YoY Change	10.07%	6.87%
SHAREHOLDERS EQUITY
Retained Earnings	$63.83M	$62.07M
YoY Change	2.84%	5.41%
Common Stock	$41.75M	$41.73M
YoY Change	0.05%	0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$12.12M	$10.23M
YoY Change	18.38%	0.0%
Treasury Stock Shares	320.2K shares	272.5K shares
Shareholders Equity	$138.1M	$139.1M
YoY Change
Total Liabilities & Shareholders Equity	$1.527B	$1.401B
YoY Change	9.0%	6.26%

Cashflow Statement

Concept	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	$3.209M	$2.686M
YoY Change	19.47%	-12.79%
Depreciation, Depletion And Amortization	$470.0K	$810.0K
YoY Change	-41.98%	-14.74%
Cash From Operating Activities	$3.624M	$4.530M
YoY Change	-20.0%	65.33%
INVESTING ACTIVITIES
Capital Expenditures	-$320.0K	-$560.0K
YoY Change	-42.86%	-23.29%
Acquisitions
YoY Change
Other Investing Activities	-$48.66M	-$20.58M
YoY Change	136.44%	-173.06%
Cash From Investing Activities	-$48.99M	-$21.14M
YoY Change	131.72%	-177.04%
FINANCING ACTIVITIES
Cash Dividend Paid	$2.204M	$2.225M
YoY Change	-0.94%	-0.13%
Common Stock Issuance & Retirement, Net	$23.00K	-$19.00K
YoY Change	-221.05%	-103.41%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$55.51M	48.59M
YoY Change	14.24%	-930.6%
NET CHANGE
Cash From Operating Activities	$3.624M	4.530M
Cash From Investing Activities	-$48.99M	-21.14M
Cash From Financing Activities	$55.51M	48.59M
Net Change In Cash	$10.15M	31.98M
YoY Change	-68.27%	31.44%
FREE CASH FLOW
Cash From Operating Activities	$3.624M	$4.530M
Capital Expenditures	-$320.0K	-$560.0K
Free Cash Flow	$3.944M	$5.090M
YoY Change	-22.51%	46.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q1	dei	Amendment Flag AmendmentFlag	false
CY2018Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018Q1	dei	Document Period End Date DocumentPeriodEndDate	2018-03-31
CY2018Q1	pwod	Financing Receivable Modifications Recorded Investment Pre Modification FinancingReceivableModificationsRecordedInvestmentPreModification	208000	USD
CY2017Q4	pwod	Financing Receivable Recorded Investment30 To89 Days Past Due FinancingReceivableRecordedInvestment30To89DaysPastDue	9744000	USD
CY2018Q1	pwod	Financing Receivable Recorded Investment30 To89 Days Past Due FinancingReceivableRecordedInvestment30To89DaysPastDue	7610000	USD
CY2018Q1	pwod	Impaired Financing Receivable Commitment To Lend ImpairedFinancingReceivableCommitmentToLend	35000	USD
CY2017Q1	pwod	Income Tax Expense On Net Realized Gain Loss Included In Net Income IncomeTaxExpenseOnNetRealizedGainLossIncludedInNetIncome	67000	USD
CY2018Q1	pwod	Income Tax Expense On Net Realized Gain Loss Included In Net Income IncomeTaxExpenseOnNetRealizedGainLossIncludedInNetIncome	-3000	USD
CY2017Q1	pwod	Loans And Leases Receivable Interest Income If Recorded On Original Loan Basis For Non Accrual Loans LoansAndLeasesReceivableInterestIncomeIfRecordedOnOriginalLoanBasisForNonAccrualLoans	653000	USD
CY2018Q1	pwod	Loans And Leases Receivable Interest Income If Recorded On Original Loan Basis For Non Accrual Loans LoansAndLeasesReceivableInterestIncomeIfRecordedOnOriginalLoanBasisForNonAccrualLoans	93000	USD
CY2018Q1	pwod	Period Consideredfor Quarter Moving Averagewhich Usedin Calculating Historical Chargeoff PeriodConsideredforQuarterMovingAveragewhichUsedinCalculatingHistoricalChargeoff	P36M
CY2018Q1	pwod	Period Financing Receivables Past Due After Which Loans Are Considered Substandard Minimum PeriodFinancingReceivablesPastDueAfterWhichLoansAreConsideredSubstandardMinimum	P90D
CY2018Q1	dei	Document Type DocumentType	10-Q
CY2018Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000716605
CY2018Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4689935	shares
CY2018Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2018Q1	dei	Entity Registrant Name EntityRegistrantName	PENNS WOODS BANCORP INC
CY2017Q1	pwod	Amortization Of Investment In Low Income Housing Limited Partnerships AmortizationOfInvestmentInLowIncomeHousingLimitedPartnerships	437000	USD
CY2018Q1	pwod	Amortization Of Investment In Low Income Housing Limited Partnerships AmortizationOfInvestmentInLowIncomeHousingLimitedPartnerships	566000	USD
CY2018Q1	pwod	Available For Sale Securities In Unrealized Loss Positions Number Of Positions Greater Than Twelve Months AvailableForSaleSecuritiesInUnrealizedLossPositionsNumberOfPositionsGreaterThanTwelveMonths	25	security
CY2018Q1	pwod	Available For Sale Securities In Unrealized Loss Positions Number Of Positions Less Than Twelve Months AvailableForSaleSecuritiesInUnrealizedLossPositionsNumberOfPositionsLessThanTwelveMonths	67	security
CY2017Q1	pwod	Debt Securities Availableforsale Realized Gain Loss DebtSecuritiesAvailableforsaleRealizedGainLoss	197000	USD
CY2018Q1	pwod	Debt Securities Availableforsale Realized Gain Loss DebtSecuritiesAvailableforsaleRealizedGainLoss	-9000	USD
CY2017Q1	pwod	Debt Securities Trading Realized Gain Loss DebtSecuritiesTradingRealizedGainLoss	2000	USD
CY2018Q1	pwod	Debt Securities Trading Realized Gain Loss DebtSecuritiesTradingRealizedGainLoss	3000	USD
CY2017Q4	pwod	Equity Securities Fvni EquitySecuritiesFVNI	2516000	USD
CY2018Q1	pwod	Equity Securities Fvni EquitySecuritiesFVNI	2482000	USD
CY2017Q1	pwod	Equity Securities Fvni Gain Loss EquitySecuritiesFVNIGainLoss	0	USD
CY2018Q1	pwod	Equity Securities Fvni Gain Loss EquitySecuritiesFVNIGainLoss	-34000	USD
CY2017Q1	pwod	Equity Securities Fvni Realized Gain Loss EquitySecuritiesFVNIRealizedGainLoss	0	USD
CY2018Q1	pwod	Equity Securities Fvni Realized Gain Loss EquitySecuritiesFVNIRealizedGainLoss	-34000	USD
CY2017Q1	pwod	Feesand Commissions Debit Cards Net FeesandCommissionsDebitCardsNet	271000	USD
CY2017Q1	pwod	Feesand Commissions Debit Cards Net FeesandCommissionsDebitCardsNet	271000	USD
CY2018Q1	pwod	Feesand Commissions Debit Cards Net FeesandCommissionsDebitCardsNet	333000	USD
CY2018Q1	pwod	Feesand Commissions Debit Cards Net FeesandCommissionsDebitCardsNet	333000	USD
CY2018Q1	pwod	Financing Receivable Individually Evaluated For Impairment Minimum Amount FinancingReceivableIndividuallyEvaluatedForImpairmentMinimumAmount	100000	USD
CY2018Q1	pwod	Financing Receivable Individually Evaluated For Impairment On Case By Case Basis Maximum Amount FinancingReceivableIndividuallyEvaluatedForImpairmentOnCaseByCaseBasisMaximumAmount	100000	USD
CY2018Q1	pwod	Financing Receivable Modification Number Of Contracts FinancingReceivableModificationNumberOfContracts	3	contract
CY2018Q1	pwod	Financing Receivable Modifications Recorded Investment Post Modification FinancingReceivableModificationsRecordedInvestmentPostModification	208000	USD
CY2017Q1	pwod	Loans And Leases Receivable Interest On Non Accrual Loans LoansAndLeasesReceivableInterestOnNonAccrualLoans	206000	USD
CY2018Q1	pwod	Loans And Leases Receivable Interest On Non Accrual Loans LoansAndLeasesReceivableInterestOnNonAccrualLoans	28000	USD
CY2018Q1	pwod	Number Of Categories Considered Not Criticized And Rated NumberOfCategoriesConsideredNotCriticizedAndRated	6	category
CY2018Q1	pwod	Number Of Classes That Groups Loans Are Collectively Evaluated For Impairment NumberOfClassesThatGroupsLoansAreCollectivelyEvaluatedForImpairment	2	class
CY2018Q1	pwod	Number Of Components Represent Allowance For Loan Losses NumberOfComponentsRepresentAllowanceForLoanLosses	2	component
CY2018Q1	pwod	Payment Delays Limit Up To Which Loans Not Classified As Impaired Maximum PaymentDelaysLimitUpToWhichLoansNotClassifiedAsImpairedMaximum	P90D
CY2017Q1	pwod	Proceeds From Redemption Of Regulatory Stock ProceedsFromRedemptionOfRegulatoryStock	1162000	USD
CY2018Q1	pwod	Proceeds From Redemption Of Regulatory Stock ProceedsFromRedemptionOfRegulatoryStock	5335000	USD
CY2018Q1	pwod	Purchaseof Trading Securities PurchaseofTradingSecurities	222000	USD
CY2017Q1	pwod	Purchaseof Trading Securities PurchaseofTradingSecurities	109000	USD
CY2018Q1	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	-1461000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	58491000	USD
CY2018Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0	USD
CY2017Q1	us-gaap	Available For Sale Securities Income Tax Expense On Change In Unrealized Holding Gain Or Loss AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss	251000	USD
CY2017Q1	pwod	Purchases Of Regulatory Stock PurchasesOfRegulatoryStock	1007000	USD
CY2018Q1	pwod	Purchases Of Regulatory Stock PurchasesOfRegulatoryStock	5486000	USD
CY2018Q1	pwod	Reasonable Period To Classify From Troubled Debt Restructuring Non Performing Loans To Performing Loans ReasonablePeriodToClassifyFromTroubledDebtRestructuringNonPerformingLoansToPerformingLoans	P6M
CY2018Q1	pwod	Reclassification Adjustment Effect On Net Income Loss ReclassificationAdjustmentEffectOnNetIncomeLoss	0	USD
CY2017Q1	pwod	Share Tax Expense ShareTaxExpense	238000	USD
CY2018Q1	pwod	Share Tax Expense ShareTaxExpense	277000	USD
CY2017Q4	pwod	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Provisional Income Tax Expense TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpense	2700000	USD
CY2017Q1	pwod	Transfer From Loans To Foreclosed Assets TransferFromLoansToForeclosedAssets	460000	USD
CY2018Q1	pwod	Transfer From Loans To Foreclosed Assets TransferFromLoansToForeclosedAssets	96000	USD
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	502000	USD
CY2018Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	793000	USD
CY2017Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-255000	USD
CY2018Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-195000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-54000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-666000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	4920000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	4886000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	50173000	USD
CY2018Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	50199000	USD
CY2017Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	67000	USD
CY2018Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	58000	USD
CY2017Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	388000	USD
CY2018Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	240000	USD
CY2017Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	90000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	80000	USD
CY2017Q4	us-gaap	Assets Assets	1474492000	USD
CY2018Q1	us-gaap	Assets Assets	1526745000	USD
CY2018Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	118643000	USD
CY2017Q1	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	739000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	57029000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	42747000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	42126000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	11861000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	11761000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	5544000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	5528000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	108627000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	116444000	USD
CY2017Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	59000	USD
CY2018Q1	us-gaap	Available For Sale Securities Income Tax Expense On Change In Unrealized Holding Gain Or Loss AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss	-306000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	262000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3070000	USD
CY2018Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	274000	USD
CY2017Q4	us-gaap	Available For Sale Securities Pledged As Collateral AvailableForSaleSecuritiesPledgedAsCollateral	95199000	USD
CY2018Q1	us-gaap	Available For Sale Securities Pledged As Collateral AvailableForSaleSecuritiesPledgedAsCollateral	70120000	USD
CY2017Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	27982000	USD
CY2018Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	28169000	USD
CY2017Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	172000	USD
CY2018Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	173000	USD
CY2017Q1	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	331000	USD
CY2018Q1	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	343000	USD
CY2017Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	273000	USD
CY2018Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	65000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43671000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75660000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27243000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37392000	USD
CY2017Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	25692000	USD
CY2018Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	18940000	USD
CY2017Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	8.33
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	8.33
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000	shares
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5009339	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5009898	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4689189	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4689748	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	41744000	USD
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	41748000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2093000	USD
CY2017Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4388000	USD
CY2018Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4721000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-39000	USD
CY2018Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-42000	USD
CY2018Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	250000	USD
CY2018Q1	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Remainder Of Fiscal Year DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear	250000	USD
CY2017Q4	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear	500000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	189000	USD
CY2018Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	176000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	7000	USD
CY2018Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-56000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	41000	USD
CY2018Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	0	USD
CY2017Q4	us-gaap	Deposits Domestic DepositsDomestic	1146320000	USD
CY2018Q1	us-gaap	Deposits Domestic DepositsDomestic	1192454000	USD
CY2017Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2225000	USD
CY2018Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2204000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.68
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.68
CY2017Q1	us-gaap	Equipment Expense EquipmentExpense	649000	USD
CY2018Q1	us-gaap	Equipment Expense EquipmentExpense	747000	USD
CY2017Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability	280281000	USD
CY2018Q1	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability	284624000	USD
CY2017Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	170000	USD
CY2018Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	202000	USD
CY2017Q4	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	70970000	USD
CY2018Q1	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	123970000	USD
CY2017Q4	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	13332000	USD
CY2018Q1	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	13483000	USD
CY2017Q1	us-gaap	Fees And Commissions Debit Cards FeesAndCommissionsDebitCards	434000	USD
CY2018Q1	us-gaap	Fees And Commissions Debit Cards FeesAndCommissionsDebitCards	333000	USD
CY2017Q1	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	528000	USD
CY2018Q1	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	551000	USD
CY2017Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	10674000	USD
CY2018Q1	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	10747000	USD
CY2017Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	2184000	USD
CY2018Q1	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	2089000	USD
CY2017Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1231896000	USD
CY2018Q1	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1264957000	USD
CY2017Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	14446000	USD
CY2018Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	15281000	USD
CY2017Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	9048000	USD
CY2018Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	9115000	USD
CY2018Q1	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	2	contract
CY2017Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	509000	USD
CY2018Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	446000	USD
CY2017Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	1229330000	USD
CY2018Q1	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	1264987000	USD
CY2017Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	6759000	USD
CY2018Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	7195000	USD
CY2017Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	197000	USD
CY2018Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-9000	USD
CY2017Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	358000	USD
CY2018Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	255000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	17104000	USD
CY2018Q1	us-gaap	Goodwill Goodwill	17104000	USD
CY2018Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	116444000	USD
CY2017Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	15418000	USD
CY2018Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	14787000	USD
CY2017Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	59000	USD
CY2018Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	165000	USD
CY2017Q1	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	26000	USD
CY2018Q1	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	28000	USD
CY2017Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	14446000	USD
CY2018Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	15281000	USD
CY2017Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	2184000	USD
CY2018Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	2089000	USD
CY2017Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	14545000	USD
CY2018Q1	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	15379000	USD
CY2017Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	3926000	USD
CY2018Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	4528000	USD
CY2017Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	3926000	USD
CY2018Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	4528000	USD
CY2017Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	10520000	USD
CY2018Q1	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	10753000	USD
CY2017Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	10619000	USD
CY2018Q1	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	10851000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3672000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3797000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	986000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	589000	USD
CY2017Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2018Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	500000	USD
CY2017Q1	us-gaap	Increase Decrease In Loans Held For Sale IncreaseDecreaseInLoansHeldForSale	10964000	USD
CY2018Q1	us-gaap	Increase Decrease In Loans Held For Sale IncreaseDecreaseInLoansHeldForSale	8762000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	1933000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-3689000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2076000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	561000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-174000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	170000	USD
CY2017Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	26500	shares
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2017Q1	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	191000	USD
CY2018Q1	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	117000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1462000	USD
CY2018Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1382000	USD
CY2017Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	11682000	USD
CY2018Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	13201000	USD
CY2017Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	10627000	USD
CY2018Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	12193000	USD
CY2017Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	843004000	USD
CY2018Q1	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	888193000	USD
CY2017Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	1551000	USD
CY2018Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	18452000	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	1346000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	2048000	USD
CY2017Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	902000	USD
CY2018Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	1222000	USD
CY2017Q1	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	440000	USD
CY2018Q1	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	602000	USD
CY2017Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	4000	USD
CY2018Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	224000	USD
CY2017Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	10006000	USD
CY2018Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	10993000	USD
CY2017Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10336000	USD
CY2018Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	11153000	USD
CY2017Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	298000	USD
CY2018Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	241000	USD
CY2017Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	542000	USD
CY2018Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	546000	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	1414000	USD
CY2018Q1	us-gaap	Interest Paid InterestPaid	1757000	USD
CY2017Q4	us-gaap	Interest Receivable InterestReceivable	4321000	USD
CY2018Q1	us-gaap	Interest Receivable InterestReceivable	4456000	USD
CY2017Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4770000	USD
CY2018Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5048000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	1336298000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	1388632000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1474492000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1526745000	USD
CY2016Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12896000	USD
CY2017Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12905000	USD
CY2017Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12858000	USD
CY2018Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12836000	USD
CY2017Q4	us-gaap	Loans And Leases Receivable Deferred Income LoansAndLeasesReceivableDeferredIncome	-272000	USD
CY2018Q1	us-gaap	Loans And Leases Receivable Deferred Income LoansAndLeasesReceivableDeferredIncome	-510000	USD
CY2017Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1246342000	USD
CY2018Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1280238000	USD
CY2017Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	1246614000	USD
CY2018Q1	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	1280748000	USD
CY2017Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1233756000	USD
CY2018Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1267912000	USD
CY2017Q4	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group Mortgage LoansReceivableHeldForSaleNetNotPartOfDisposalGroupMortgage	1196000	USD
CY2018Q1	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group Mortgage LoansReceivableHeldForSaleNetNotPartOfDisposalGroupMortgage	748000	USD
CY2017Q1	us-gaap	Marketing Expense MarketingExpense	171000	USD
CY2018Q1	us-gaap	Marketing Expense MarketingExpense	251000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	2000	USD
CY2018Q1	us-gaap	Minority Interest MinorityInterest	1000	USD
CY2017Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	378000	USD
CY2018Q1	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	386000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	31989000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	10149000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	48592000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	55510000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-21135000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-45297000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	4532000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-64000	USD
CY2017Q1	us-gaap	Net Change Interest Bearing Deposits Domestic NetChangeInterestBearingDepositsDomestic	56335000	USD
CY2018Q1	us-gaap	Net Change Interest Bearing Deposits Domestic NetChangeInterestBearingDepositsDomestic	45189000	USD
CY2017Q1	us-gaap	Net Change Noninterest Bearing Deposits Domestic NetChangeNoninterestBearingDepositsDomestic	9115000	USD
CY2018Q1	us-gaap	Net Change Noninterest Bearing Deposits Domestic NetChangeNoninterestBearingDepositsDomestic	945000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	2686000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	3209000	USD
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2018Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2686000	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3208000	USD
CY2017Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	303316000	USD
CY2018Q1	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	304261000	USD
CY2017Q1	us-gaap	Noninterest Expense NoninterestExpense	8985000	USD
CY2018Q1	us-gaap	Noninterest Expense NoninterestExpense	9277000	USD
CY2017Q1	us-gaap	Noninterest Income NoninterestIncome	2651000	USD
CY2018Q1	us-gaap	Noninterest Income NoninterestIncome	2081000	USD
CY2017Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	438000	USD
CY2018Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	349000	USD
CY2017Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1216744000	USD
CY2018Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1252661000	USD
CY2017Q1	us-gaap	Occupancy Net OccupancyNet	638000	USD
CY2018Q1	us-gaap	Occupancy Net OccupancyNet	741000	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	4989000	USD
CY2018Q1	us-gaap	Other Assets OtherAssets	4706000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	488000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-1155000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	384000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1115000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-39000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-42000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-13000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-8000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	197000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-9000	USD
CY2017Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	719000	USD
CY2018Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	386000	USD
CY2017Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	215000	USD
CY2018Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	221000	USD
CY2017Q4	us-gaap	Other Liabilities OtherLiabilities	17758000	USD
CY2018Q1	us-gaap	Other Liabilities OtherLiabilities	12110000	USD
CY2017Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1549000	USD
CY2018Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1300000	USD
CY2017Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2018Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2017Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	18200000	USD
CY2018Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	35900000	USD
CY2017Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	557000	USD
CY2018Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	323000	USD
CY2017Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2225000	USD
CY2018Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2204000	USD
CY2017Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	9699000	USD
CY2018Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	12935000	USD
CY2017Q1	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	30000	USD
CY2018Q1	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	27000	USD
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2018Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	0	USD
CY2018Q1	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	55000000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	19000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	23000	USD
CY2017Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3958000	USD
CY2018Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	660000	USD
CY2017Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-4652000	USD
CY2018Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-41443000	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	2652000	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	3363000	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	586000	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	16000	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	12054000	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	9465000	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	169000	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	233000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	2686000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	3208000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27386000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27587000	USD
CY2017Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	330000	USD
CY2018Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	160000	USD
CY2017Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	422000	USD
CY2018Q1	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	558000	USD
CY2017Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	104000	USD
CY2018Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-40000	USD
CY2017Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	10000000	USD
CY2018Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	2000000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	63364000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	63832000	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.00
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.00
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	12250	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	38750	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	70000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	25000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	26500	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	96500	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	93500	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	118500	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	26500	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	42.03
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	43.61
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	43.59
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	43.91
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	0	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	0	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2017Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.00
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.00
CY2017Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.00
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.00
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4689376	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	42.03
CY2017Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	44.21
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	45.11
CY2017Q1	us-gaap	Share Price SharePrice	46.94
CY2018Q1	us-gaap	Share Price SharePrice	41.93
CY2015Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2017Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	100748000	USD
CY2018Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	59305000	USD
CY2017Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2018Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2017Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	14000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	23000	USD
CY2017Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	138192000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	138112000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	138249000	USD
CY2017Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	139113000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	138194000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	138113000	USD
CY2017Q4	us-gaap	Trading Securities TradingSecurities	190000	USD
CY2018Q1	us-gaap	Trading Securities TradingSecurities	159000	USD
CY2017Q1	us-gaap	Trading Securities Realized Gain Loss TradingSecuritiesRealizedGainLoss	2000	USD
CY2018Q1	us-gaap	Trading Securities Realized Gain Loss TradingSecuritiesRealizedGainLoss	3000	USD
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	320150	shares
CY2018Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	320150	shares
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	12115000	USD
CY2018Q1	us-gaap	Treasury Stock Value TreasuryStockValue	12115000	USD
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4761305	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	5007257	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	5009526	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4734805	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4689376	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	272452	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	320150	shares
CY2018Q1	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;">. The standard requires lessees to recognize the assets and liabilities that arise from leases on the balance sheet.  A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term.  A short-term lease is defined as one in which (a) the lease term is 12 months or less and (b) there is not an option to purchase the underlying asset that the lessee is reasonably certain to exercise. For short-term leases, lessees may elect to recognize lease payments over the lease term on a straight-line basis. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, and interim periods within those years. For all other entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2019, and for interim periods within fiscal years beginning after December 15, 2020. The amendments should be applied at the beginning of the earliest period presented using a modified retrospective approach with earlier application permitted as of the beginning of an interim or annual reporting period. The Company is currently assessing the practical expedients it may elect at adoption, but does not anticipate the amendments will have a significant impact on the financial statements. Based on the Company’s preliminary analysis of its current portfolio, the impact to the Company’s balance sheet is estimated to result in less than a </font><font style="font-family:inherit;font-size:10pt;">1</font><font style="font-family:inherit;font-size:10pt;"> percent increase in assets and liabilities. The Company also anticipates additional disclosures to be provided at adoption.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments</font><font style="font-family:inherit;font-size:10pt;">, which changes the impairment model for most financial assets. This Update is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The underlying premise of the Update is that financial assets measured at amortized cost should be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The allowance for credit losses should reflect management’s current estimate of credit losses that are expected to occur over the remaining life of a financial asset. The income statement will be effected for the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. ASU 2016-13 is effective for annual and interim periods beginning after December 15, 2019, and early adoption is permitted for annual and interim periods beginning after December 15, 2018. With certain exceptions, transition to the new requirements will be through a cumulative effect adjustment to opening retained earnings as of the beginning of the first reporting period in which the guidance is adopted. We expect to recognize a one-time cumulative effect adjustment to the allowance for loan losses as of the beginning of the first reporting period in which the new standard is effective, but cannot yet determine the magnitude of any such one-time adjustment or the overall impact of the new guidance on the consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU 2017-04, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Simplifying the Test for Goodwill Impairment</font><font style="font-family:inherit;font-size:10pt;">. To simplify the subsequent measurement of goodwill, the FASB eliminated Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under the amendments in this Update, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting units fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. A public business entity that is a U.S. Securities and Exchange Commission (SEC) filer should adopt the amendments in this Update for its annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. A public business entity that is not an SEC filer should adopt the amendments in this Update for its annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2020. All other entities, including not-for-profit entities, that are adopting the amendments in this Update should do so for their annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2021. This Update is not expected to have a significant impact on the Company’s financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2017, the FASB issued ASU 2017-06</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, Plan Accounting: Defined Benefit Pension Plans (Topic 960), Defined Contribution Pension Plans (Topic 962), and Health and Welfare Benefit Plans (Topic 965)</font><font style="font-family:inherit;font-size:10pt;">. </font><font style="font-family:inherit;font-size:10pt;color:#252525;">This Update relates primarily to the reporting by an employee benefit plan for its interest in a master trust, which is a trust for which a regulated financial institution serves as a trustee or custodian and in which assets of more than one plan sponsored by a single employer or by a group of employers under common control are held. For each master trust in which a plan holds an interest, the amendments in this Update require a plan's interest in that master trust and any change in that interest to be presented in separate line items in the statement of net assets available for benefits and in the statement of changes in net assets available for benefits, respectively. The amendments in this Update remove the requirement to disclose the percentage interest in the master trust for plans with divided interests and require that all plans disclose the dollar amount of their interest in each of those general types of investments, which supplements the existing requirement to disclose the master trusts balances in each general type of investments. There are also increased disclosure requirements for investments in master trusts. The amendments in this Update are effective for fiscal years beginning after December 15, 2018. Early adoption is permitte</font><font style="font-family:inherit;font-size:10pt;">d. This Update is not expected to have a significant impact on the Company’s financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2017, the FASB issued ASU 2017-08, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20).</font><font style="font-family:inherit;font-size:10pt;"> The amendments in this Update shorten the amortization period for certain callable debt securities held at a premium. Specifically, the amendments require the premium to be amortized to the earliest call date. The amendments do not require an accounting change for securities held at a discount; the discount continues to be amortized to maturity. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. An entity should apply the amendments in this Update on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. Additionally, in the period of adoption, an entity should provide disclosures about a change in accounting principle. This Update is not expected to have a significant impact on the Company’s financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2017, the FASB issued ASU 2017-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), and Derivative and Hedging (Topic 815)</font><font style="font-family:inherit;font-size:10pt;">. The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down-round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down-round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down-round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down-round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down- round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Debt-Debt with Conversion and Other Options</font><font style="font-family:inherit;font-size:10pt;">), including related EPS guidance (in Topic 260). The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Accounting Standards Codification, to a scope exception. Those amendments do not have an accounting effect. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments in Part I of this Update should be applied either retrospectively to outstanding financial instruments with a down-round feature by means of a cumulative-effect adjustment to the statement of financial position as of the beginning of the first fiscal year and interim period(s) in which the pending content that links to this paragraph is effective or retrospectively to outstanding financial instruments with a down-round feature for each prior reporting period presented in accordance with the guidance on accounting changes in paragraphs 250-10-45-5 through 45-10. The amendments in Part II of this Update do not require any transition guidance because those amendments do not have an accounting effect. This Update is not expected to have a significant impact on the Company’s financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2017, the FASB issued ASU 2017-12, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging (Topic 850)</font><font style="font-family:inherit;font-size:10pt;">, the objective of which is to improve the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. In addition, the amendments in this Update make certain targeted improvements to simplify the application and disclosure of the hedge accounting guidance in current general accepted accounting principles. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods beginning after December 15, 2020. Early application is permitted in any period after issuance. For cash flow and net investment hedges existing at the date of adoption, an entity should apply a cumulative-effect adjustment related to eliminating the separate measurement of ineffectiveness to accumulated other comprehensive income with a corresponding adjustment to the opening balance of retained earnings as of the beginning of the fiscal year that an entity adopts the amendments in this Update. The amended presentation and disclosure guidance is required only prospectively. This Update is not expected to have a significant impact on the Company’s financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2018, the FASB issued ASU 2018-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;">, which provides an optional transition practical expedient to not evaluate under Topic 842 existing or expired land easements that were not previously accounted for as leases under the current lease guidance in Topic 840. An entity that elects this practical expedient should evaluate new or modified land easements under Topic 842 beginning at the date the entity adopts Topic 842; otherwise, an entity should evaluate all existing or expired land easements in connection with the adoption of the new lease requirements in Topic 842 to assess whether they meet the definition of a lease. The effective date and transition requirements for the amendments are the same as the effective date and transition requirements in ASU 2016-02. This Update is not expected to have a significant impact on the Company’s financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, the FASB issued ASU 2018-03, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Technical Corrections and Improvements to Financial Instruments-Overall (Subtopic 825-10)</font><font style="font-family:inherit;font-size:10pt;">, to clarify certain aspects of the guidance issued in ASU 2016-01. (1) An entity measuring an equity security using the measurement alternative may change its measurement approach to a fair value method in accordance with Topic 820, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement</font><font style="font-family:inherit;font-size:10pt;">, through an irrevocable election that would apply to that security and all identical or similar investments of the same issuer. Once an entity makes this election, the entity should measure all future purchases of identical or similar investments of the same issuer using a fair value method in accordance with Topic 820. (2) Adjustments made under the measurement alternative are intended to reflect the fair value of the security as of the date that the observable transaction for a similar security took place. (3) Remeasuring the entire value of forward contracts and purchased options is required when observable transactions occur on the underlying equity securities. (4) When the fair value option is elected for a financial liability, the guidance in paragraph 825-10-45-5 should be applied, regardless of whether the fair value option was elected under either Subtopic 815-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging-Embedded Derivatives</font><font style="font-family:inherit;font-size:10pt;">, or 825-10, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments-Overall</font><font style="font-family:inherit;font-size:10pt;">. (5) Financial liabilities for which the fair value option is elected, the amount of change in fair value that relates to the instrument specific credit risk should first be measured in the currency of denomination when presented separately from the total change in fair value of the financial liability. Then, both components of the change in the fair value of the liability should be remeasured into the functional currency of the reporting entity using end-of-period spot rates. (6) The prospective transition approach for equity securities without a readily determinable fair value in the amendments in Update 2016-01 is meant only for instances in which the measurement alternative is applied. An insurance entity subject to the guidance in Topic 944, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Services- Insurance</font><font style="font-family:inherit;font-size:10pt;">, should apply a prospective transition method when applying the amendments related to equity securities without readily determinable fair values. An insurance entity should apply the selected prospective transition method consistently to the entity’s entire population of equity securities for which the measurement alternative is elected. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years beginning after June 15, 2018. Public business entities with fiscal years beginning between December 15, 2017, and June 15, 2018, are not required to adopt these amendments until the interim period beginning after June 15, 2018, and public business entities with fiscal years beginning between June 15, 2018, and December 15, 2018, are not required to adopt these amendments before adopting the amendments in Update 2016-01. For all other entities, the effective date is the same as the effective date in Update 2016-01. All entities may early adopt these amendments for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, as long as they have adopted Update 2016-01. The Company is currently evaluating the impact the adoption of the standard will have on the Company’s financial position or results of operations.</font></div></div>

Files In Submission

Name	View Source	Status
0000716605-18-000012-index-headers.html	Edgar Link	pending
0000716605-18-000012-index.html	Edgar Link	pending
0000716605-18-000012.txt	Edgar Link	pending
0000716605-18-000012-xbrl.zip	Edgar Link	pending
a20181q18-10xq.htm	Edgar Link	pending
ex311-1q18.htm	Edgar Link	pending
ex312-1q18.htm	Edgar Link	pending
ex321-1q18.htm	Edgar Link	pending
ex322-1q18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pwod-20180331.xml	Edgar Link	completed
pwod-20180331.xsd	Edgar Link	pending
pwod-20180331_cal.xml	Edgar Link	unprocessable
pwod-20180331_def.xml	Edgar Link	unprocessable
pwod-20180331_lab.xml	Edgar Link	unprocessable
pwod-20180331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PWOD
PENNS WOODS BANCORP INC Stock $pwod

2018 Q1 Form 10-Q Financial Statement

#000071660518000012 Filed on May 10, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PWOD PENNS WOODS BANCORP INC Stock $pwod

2018 Q1 Form 10-Q Financial Statement

#000071660518000012 Filed on May 10, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PWOD
PENNS WOODS BANCORP INC Stock $pwod